Emergent BioSolutions Inc (EBS.N)

EBS.N on New York Stock Exchange

17.73USD
10:44am EDT
Price Change (% chg)

$0.04 (+0.23%)
Prev Close
$17.69
Open
$17.80
Day's High
$17.80
Day's Low
$17.66
Volume
8,183
Avg. Vol
50,833
52-wk High
$18.25
52-wk Low
$12.50

EBS.N

Chart for EBS.N

About

Emergent BioSolutions Inc. is a biopharmaceutical company focused on protecting and enhancing life by developing and manufacturing vaccines and antibody therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. The Company operates in two divisions: BioDefense Division and... (more)

Overall

Beta: -0.03
Market Cap (Mil.): $638.99
Shares Outstanding (Mil.): 36.12
Dividend: --
Yield (%): --

Financials

  EBS.N Industry Sector
P/E (TTM): 28.99 37.93 37.76
EPS (TTM): 0.61 -- --
ROI: 3.60 19.48 18.76
ROE: 5.27 20.17 19.59
Search Stocks

RPT-BRIEF-Emergent Biosolutions to expand clinical trial of TRU-016 and rituximab

April 5 - April 5 - Emergent Biosolutions Inc : * To expand front line CLL clinical trial of TRU-016 and rituximab based on strong patient enrollment and encouraging early clinical data * Source text for Eikon * Further company coverage

05 Apr 2013

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$15.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks